Icotinib (BPI-2009H) is a potent and novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with an IC50 of 5 nM. Iconitib inhibits the proliferation of A431 and BGC-823 A549, H460 and KB cell lines with IC50s of 1, 4.06, 12.16, 16.08, 40.71 µM.
Molecular Weight:
391.4
Purity:
>99%
CAS Number:
[610798-31-7]
Formula:
C22H21N3O4
Target:
EGFR/HER2
* VAT and and shipping costs not included. Errors and price changes excepted